Glenmark Life Sciences is likely to announce its share allotment status on August 3. The issue size of the speciality chemical manufacturer was subscribed 45.08 times on the third and final day of ...

Shares of Glenmark Life Sciences list at over 4% premium from its price band of ₹695-720 per share. The IPO was subscribed 45.08 times on the last day of the bidding. The market capitalisation ...

Glenmark Life Sciences Limited was incorporated as Zorg ... The Company came up with an IPO of 21,022,222 Equity Shares comprising a Fresh Issue of 14,722,222 Equity Shares and Offer for Sale ...

Glenmark Life Sciences Q4: Glenmark Life Sciences on Thursday said its net profit declined 33 per cent to Rs 98 crore for the March quarter ended March 31, 2024. The company had posted a net ...

Read more about the key elements of IPO preparation and watch our webinar. For life sciences companies considering an IPO in 2025, now is the time to begin preparations. While market conditions ...

Alivus Life Sciences Ltd share price was up by 4.00% from the previous closing price of ₹1,024.05. Who are peers of Alivus Life Sciences Ltd? The peers of Alivus Life Sciences Ltd are Sun ...

UltraTech Cement, Maruti Suzuki India, Sun Pharma Advanced Research Company, Glenmark Life Sciences, Hindustan Zinc, Godawari Power and Ispat, Manappuram Finance, Jubilant Pharmova, and Strides ...

Jan 23 (Reuters) - Indian drugmaker Alivus Life Sciences (ALIV.NS), opens new tab, formerly called Glenmark Life Sciences, reported a higher third-quarter profit on Thursday, driven by strong ...

Dublin, Ireland, and Mumbai, India and London, United Kingdom--(Newsfile Corp. - February 10, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo ...